Human blood eosinophils exhibit a hyper-active phenotype in response to chemotactic factors following cell “priming” with IL-5 family cytokines. Earlier work has identified ERK1/2 as molecular markers for IL-5 priming, and herein we show that IL-3, a member of IL-5 family, also augments fMLP-stimulated ERK1/2 phosphorylation in primary eosinophils. Besides ERK1/2, we also observed an enhancement of chemotactic factor-induced Akt phosphorylation following IL-5 priming of human blood eosinophils. Administration of a peptide antagonist that targets the Src family member Lyn prior to cytokine (IL-5/IL-3) priming of blood eosinophils inhibited the synergistic increase of fMLP-induced activation of Ras, ERK1/2 and Akt, as well as the release of the proinflammatory factor leukotriene-C4. In the current study, we also examined a human eosinophil-like cell line HL-60 clone-15, and observed that these cells exhibited significant surface expression of IL-3 and GM-CSF receptors, as well as ERK1/2 phosphorylation in response to the addition of IL-5 family cytokines or the chemotactic factors fMLP, CCL5 and CCL11. Consistent with the surface profile of IL-5 family receptors, HL-60 clone-15 recapitulated the enhanced fMLP-induced ERK1/2 phosphorylation observed in primary blood eosinophils following priming with IL-3/GM-CSF, and siRNA-mediated knockdown of Lyn expression completely abolished the synergistic effects of IL-3 priming on fMLP-induced ERK1/2 phosphorylation. Altogether, our data reveal a central role for Lyn in the mechanisms of IL-5 family priming, and suggest that Lyn contributes to the up-regulation of the Ras-ERK1/2 and PI3K-Akt cascades as well as the increased leukotriene-C4 release observed in response to fMLP in “primed” eosinophils.